Cibus delays U.

Cibus delays U.S. rice launch to 2029
Cibus announced a strategic timeline shift during its Q1 2026 earnings call, pushing its U.S. rice product launch to 2029 while maintaining its Latin American market entry for 2027. The gene-edited rice developer disclosed it has sufficient cash runway extending into late Q1 2027, providing the company a window to advance its regulatory approvals and market preparation. The delay reflects the extended timeline required for U.S. regulatory processes, though the company remains on track for earlier international expansion. Additionally, Cibus highlighted momentum in its biofragrance division, which is ramping production and contributing to revenue diversification. The strategic shift prioritizes establishing market presence in Latin America before tackling the more stringent U.S.